Skip to main content
Article
Allogeneic hematopoietic cell transplantation after conditioning with 131I―anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome
Blood (2009)
  • John M. Pagel, University of Washington
  • Theodore A. Gooley, Fred Hutchinson Cancer Research Center
  • Joseph Rajendran, University of Washington
  • Darrell R. Fisher, Pacific Northwest National Laboratory
  • Wendy A. Wilson, Fred Hutchinson Cancer Research Center
  • Brenda M. Sandmaier, University of Washington
  • Dana C. Matthews, University of Washington
  • H. Joachim Deeg, University of Washington
  • Ajay K. Gopal, University of Washington
  • Paul J. Martin, University of Washington
  • Rainer F. Storb, University of Washington
  • Oliver W. Press, University of Washington
  • Frederick R. Appelbaum, University of Washington
Publication Date
December 24, 2009
DOI
10.1182/blood-2009-03-213298
Citation Information
John M. Pagel, Theodore A. Gooley, Joseph Rajendran, Darrell R. Fisher, et al.. "Allogeneic hematopoietic cell transplantation after conditioning with 131I―anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome" Blood Vol. 114 Iss. 27 (2009) p. 5444 - 5453
Available at: http://works.bepress.com/john-pagel/208/